Grace Therapeutics Files 8-K
Ticker: GRCE · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1444192
| Field | Detail |
|---|---|
| Company | Grace Therapeutics, INC. (GRCE) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, name-change
TL;DR
Grace Therapeutics (fka Acasti Pharma) filed an 8-K on 6/25/25. Nothing major disclosed yet.
AI Summary
Grace Therapeutics, Inc. filed an 8-K on June 25, 2025, reporting on other events and financial statements. The company, formerly known as Acasti Pharma Inc. until August 28, 2008, is incorporated in Delaware and headquartered in Princeton, New Jersey.
Why It Matters
This filing indicates ongoing corporate activity and reporting requirements for Grace Therapeutics, Inc., formerly Acasti Pharma Inc.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and 'Financial Statements and Exhibits' without specific material disclosures of new risks.
Key Numbers
- 001-35776 — SEC File Number (Identifies the company's filing with the SEC.)
- 98-1359336 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Grace Therapeutics, Inc. (company) — Registrant
- Acasti Pharma Inc. (company) — Former company name
- June 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Princeton, New Jersey (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item, but the specific details of these events are not provided in the excerpt.
When did Grace Therapeutics, Inc. change its name from Acasti Pharma Inc.?
The company's name was changed from Acasti Pharma Inc. on August 28, 2008.
Where are Grace Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 103 Carnegie Center, Suite 300, Princeton, New Jersey 08540.
What is the SIC code for Grace Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Grace Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Grace Therapeutics, Inc.?
The fiscal year end for Grace Therapeutics, Inc. is March 31 (0331).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding Grace Therapeutics, Inc. (GRCE).